Characteristics of adrenocortical carcinoma associated with Lynch Syndrome.
暂无分享,去创建一个
C. Lázaro | G. Capellá | C. Carrato | J. Brunet | A. Izquierdo | M. Navarro | M. Pineda | J. Del Valle | M. Domènech | Núria Dueñas | Èlia Grau | A. Solanes | M. Pujol | J. del Valle
[1] E. Martinelli,et al. Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] Aung Ko Win,et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database , 2019, Genetics in Medicine.
[3] P. Møller,et al. The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome , 2019, Genetics in Medicine.
[4] Ravinder J. Singh,et al. Adrenal Cortical Carcinoma Associated With Lynch Syndrome: A Case Report and Review of Literature , 2019, Journal of the Endocrine Society.
[5] P. Keegan,et al. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors , 2019, Clinical Cancer Research.
[6] Ahmet Zehir,et al. Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Aung Ko Win,et al. Cancer Risks for PMS2-Associated Lynch Syndrome. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] P. Salman,et al. Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer , 2018, OncoTargets and therapy.
[9] T. Else,et al. Adrenocortical carcinoma (ACC): When and why should we consider germline testing? , 2018, Presse medicale.
[10] H. Cathro,et al. Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas , 2018, The American journal of surgical pathology.
[11] J. Gilbert,et al. Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome , 2018, Familial Cancer.
[12] D. Evans,et al. Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome , 2017, JAMA oncology.
[13] Ludmila V. Danilova,et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.
[14] P. Møller,et al. Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database , 2016, Gut.
[15] Aung Ko Win,et al. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer , 2016, Cancer Epidemiology, Biomarkers & Prevention.
[16] S. Nik-Zainal,et al. Familial Adrenocortical Carcinoma in Association With Lynch Syndrome , 2016, The Journal of clinical endocrinology and metabolism.
[17] C. Rodríguez-Galindo,et al. 5th International ACC Symposium: Hereditary Predisposition to Childhood ACC and the Associated Molecular Phenotype , 2016, Hormones and Cancer.
[18] P. Møller,et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database , 2015, Gut.
[19] Bert Vogelstein,et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.
[20] S. Ranganathan,et al. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation. , 2015, Journal of pediatric hematology/oncology.
[21] S. Gruber,et al. Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. , 2014, JAMA dermatology.
[22] R. Pai,et al. Lynch Syndrome Screening Should Be Considered for All Patients With Newly Diagnosed Endometrial Cancer , 2014, The American journal of surgical pathology.
[23] J. Church,et al. Guidelines on Genetic Evaluation and Management of Lynch Syndrome: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer , 2014, The American Journal of Gastroenterology.
[24] Rodney J Scott,et al. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database , 2013, Nature Genetics.
[25] Larissa V Furtado,et al. Adrenocortical carcinoma is a lynch syndrome-associated cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] P. Møller,et al. Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts , 2013, Gut.
[27] S. Gruber,et al. Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.
[28] J. Potter,et al. Identification of Lynch syndrome among patients with colorectal cancer. , 2012, JAMA.
[29] C. Sempoux,et al. Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature. , 2012, Human pathology.
[30] M. Fassnacht,et al. TP53 germline mutations in adult patients with adrenocortical carcinoma. , 2012, The Journal of clinical endocrinology and metabolism.
[31] A. Tabarin,et al. Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database. , 2012, European journal of endocrinology.
[32] L. González,et al. Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome , 2011, Familial Cancer.
[33] Heather Hampel,et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Martin Fassnacht,et al. Adrenocortical Carcinoma: Clinical Update , 2006 .
[35] Electron Kebebew,et al. Extent of Disease at Presentation and Outcome for Adrenocortical Carcinoma: Have We Made Progress? , 2006, World Journal of Surgery.
[36] R. Broaddus,et al. Unusual tumors associated with the hereditary nonpolyposis colorectal cancer syndrome , 2004, Modern Pathology.
[37] A. Cats,et al. Adrenocortical adenocarcinoma in an MSH2 carrier: coincidence or causal relation? , 2000, Human pathology.
[38] P. Boyle,et al. Cancer registration: principles and methods. Statistical methods for registries. , 1991, IARC scientific publications.